Tenon Medical (NASDAQ: TNON) down 40% on ghastly mess of capital reorganisation

Tenon Medical (NASDAQ: TNON) stock is down 39% and then another 10% again as a result of a really badly handled capital reorganisation. Sure, sometimes these things are necessary, just have to be done. But doing them this badly - and destroying this much value in the process - really doesn’t reflect well upon management. 

As to what’s done at Tenon: “Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints.”

Sadly Tenon is not doing this very well. So badly that they had a stock issue back in June to raise $5 million and change. Then appeared to be coming back to market in September to do the same again. The stock fell badly when that second was announced - then rose back again when it was cancelled. It was likely a shelf registration being announced rather than an actual offer. But coming so soon after the earlier capital raise it wasn’t a good look all the same. 

Tenon Medical

Tenon Medical stock price from Google Finance

The problem today is that they announced a reverse stock split. Well, OK, gotta keep that Nasdaq listing going and all that. Got to stay above that $1 minimum bid price. So, a reverse stock split then: “Tenon Medical, Inc. (TNON) will effect a one-for-ten (1-10) reverse split of its Common Stock. The reverse stock split will become effective on Thursday, November 2, 2023.”

But upon the announcement of this the TNON stock price dropped 39%, as we can see. It shouldn’t do that but perhaps it was just the shock of the announcement that did it. What’s worse is the continued reaction this morning. After a one for 10 the stock price should be up 1,000%, or 10x. But it’s only up that just under 900% - that’s another 10% loss off that already down 39% position.

A reverse stock split really shouldn’t have this effect. But it has, presumably as result of the surprise to the market. Making such a ghastly mess of a simple capital reorganisation like this really doesn’t reflect well upon Tenon Medical management. Even, possibly, diminishes our desire to invest with them.